Parenteral Antibiotic Administration on Persistence of VRE

REFERENCES 1. Banerjee SN, Emori TG, Culver DA, Gaynes RP, Jarvis WR, Horan T, et al. Secular trends in nosocomial primary bloodstream infections in the United States. National Nosocomial Infectious Surveillance System. Am J Med 1991;91(suppl 3B):865-895. 2. Komshian SV, Uwaydah AK, Sobel JD, Crane L Fungemia caused by Candida sp and Torulopsis glabrata in hospitalized patients frequency, characteristics and evaluation of factors influencing outcome. Rev Infect Dis 1989;3:379-390. 3. Wey SB, Motomi M, Pfaller MA, Woolsen RF, Wenzel RP. Hospital acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988;148:2642-2647. 4. Vazquez JA, Sanchez V, Dmuchowski C, Dembry LM, Sobel JD, Zervos MJ. Nosocomial acquisition of Candida albicans: an epidemiologic study. J Infect Dis 1993;168:195-201. 5. Sanchez V, Vazquez J, Jones DB, Dembry L, Sobel JD, Zervos MJ. Nosocomial acquisition of Candida parapsilosis: an epidemiologic study. Am J Med 1993;94:577-582. 6. Sanchez V, Vazquez JA, Barth-Jones D, Dembry L, Sobel JD, Zervos MJ. Epidemiology of nosocomial acquisition of Candida lusitaniae. J Clin Microbiol 1993;30:3005-3008. 7. Vazquez JA, Dembry LM, Sanchez V, Vazquez MA, Sobel JD, Dmuchowski C, Zervos MJ. Nosocomial Candida glabrata colonization: an epidemiologic study./ Clin Microbiol 1998;36:421-426. 8. Isenberg HD, Tucci V, Clintron F, Sincer C, Weinstein GS, Tyras D. Single source outbreak of Candida tropicalis complicating coronary bypass surgery./ Clin Microbiol 1989;27:2426-2428. 9. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995;20:1526-1530. 10. Vaudry WL, Tierney AJ, Weinman. Investigating of cluster of systemic Candida albicans infections in a neonatal intensive care unit. / Infect Dis 1988;158:1375-1379. 11. Weems JJ, Chamberland ME, Ward J, Willy M, Payne AA, Solomon SL. Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. / Clin Microbiol 1987; 1925:1029-1032. 12. Burnie JP, Odds FC, Lee W, Webster C, Williams JD. Outbreak of systemic Candida albicans in an intensive care unit caused by cross infection. BMJ 1985;290:746-748. 13. Berkelman RL Holland BW, Anderson R. Increased bactericidal activity of dilute preparations of Clinidine solutions./ Clin Microbiol 1982;15:635639. 14. Haley CE, Mailing-Casin M, Smith J, Luby J, Mackowiak P Bactericidal activity of antiseptics against methicillin resistant Staphylococcus aureus. J Clin Microbiol 1985;21:991-992. 15. Russell AD, Ahonkhai I, Rogers DT. Microbiological applications of the inactivation of antibiotics and other antimicrobial agents. / Appl Bacteriol 1979;46:207-245. 16. Phelps M, Ayliffe GAJ, Babb JR An outbreak of candidiasis in a special care unit the use of resitogram typing method. / Hosp Infect 1986;7:1320. 17. Maki DG, Alvarado CJ, Hassemr CA, Zilz MA Relation of the inanimate hospital environment to endemic nosocomial infection. N Engl J Med 1982;307:1562-1566. 18. Nicoletti G, Boghossian V, Gurevitch F, Borland R, Morganroth P. The antimicrobial activity in vitro of chlorhexidine, a mixture of isothiazolinones ('Kathon' CG) and cetyl trimethyl ammonium bromide (CTAB)./ Hosp Infect 1993;23:87-111.

[1]  J. Sobel,et al.  Nosocomial Candida glabrata Colonization: an Epidemiologic Study , 1998, Journal of Clinical Microbiology.

[2]  W. Jarvis Epidemiology of nosocomial fungal infections, with emphasis on Candida species. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  J. Sobel,et al.  Nosocomial acquisition of Candida albicans: an epidemiologic study. , 1993, The Journal of infectious diseases.

[4]  J. Sobel,et al.  Nosocomial acquisition of Candida parapsilosis: an epidemiologic study. , 1993, The American journal of medicine.

[5]  G. Nicoletti,et al.  The antimicrobial activity in vitro of chlorhexidine, a mixture of isothiazolinones ('Kathon' CG) and cetyl trimethyl ammonium bromide (CTAB). , 1993, The Journal of hospital infection.

[6]  J. Sobel,et al.  Epidemiology of nosocomial acquisition of Candida lusitaniae , 1992, Journal of clinical microbiology.

[7]  W J Martone,et al.  Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. , 1991, The American journal of medicine.

[8]  D. Tyras,et al.  Single-source outbreak of Candida tropicalis complicating coronary bypass surgery , 1989, Journal of clinical microbiology.

[9]  J. Sobel,et al.  Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. , 1989, Reviews of infectious diseases.

[10]  R F Woolson,et al.  Hospital-acquired candidemia. The attributable mortality and excess length of stay. , 1988, Archives of internal medicine.

[11]  S. Solomon,et al.  Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers , 1987, Journal of clinical microbiology.

[12]  P. Mackowiak,et al.  Bactericidal activity of antiseptics against methicillin-resistant Staphylococcus aureus , 1985, Journal of clinical microbiology.

[13]  F. Odds,et al.  Outbreak of systemic Candida albicans in intensive care unit caused by cross infection. , 1985, British medical journal.

[14]  D. Maki,et al.  Relation of the inanimate hospital environment to endemic nosocomial infection. , 1982, The New England journal of medicine.

[15]  D. T. Rogers,et al.  Microbiological applications of the inactivation of antibiotics and other antimicrobial agents. , 1979, The Journal of applied bacteriology.